- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 938780, 6 pages
Sensitive HPV Genotyping Based on the Flow-Through Hybridization and Gene Chip
1Department of Gynecology, Shaoxing People’s Hospital and Shaoxing Hospital of Zhejiang University, Shaoxing 312000, China
2Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Hepingli, Beijing 100029, China
Received 13 July 2012; Revised 7 September 2012; Accepted 13 September 2012
Academic Editor: F. C. Schmitt
Copyright © 2012 Pingping Tao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. M. McLachlin, “Human papillomavirus in cervical neoplasia: role, risk factors, and implications,” Clinics in Laboratory Medicine, vol. 20, no. 2, pp. 257–270, 2000.
- M. Poljak, “Review of 20 years of HPV research in Slovenia,” Acta Dermatovenerol Alp Panonica Adriat, vol. 20, pp. 99–112, 2011.
- N. Muñoz, F. X. Bosch, S. De Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003.
- N. Muñoz, F. Méndez, H. Posso et al., “Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results,” Journal of Infectious Diseases, vol. 190, no. 12, pp. 2077–2087, 2004.
- A. Ermel, B. Qadadri, A. Morishita et al., “Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay,” Journal of Virological Methods, vol. 169, no. 1, pp. 154–161, 2010.
- C. Clavel, M. Masure, J. P. Bory et al., “Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women,” British Journal of Cancer, vol. 84, no. 12, pp. 1616–1623, 2001.
- P. E. Castle, A. T. Lorincz, I. Mielzynska-Lohnas et al., “Results of human papillomavirus DNA testing with the Hybrid Capture 2 assay are reproducible,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 1088–1090, 2002.
- A. Sargent, A. Bailey, A. Turner et al., “Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial,” Journal of Clinical Microbiology, vol. 48, no. 2, pp. 554–558, 2010.
- F. Pei, X. P. Chen, Y. Zhang et al., “Human papillomavirus infection in nasal polyps in a Chinese population,” Journal of General Virology, vol. 92, no. 8, pp. 1795–1799, 2011.
- K. Shigehara, T. Sasagawa, J. Doorbar et al., “Etiological role of human papillomavirus infection for inverted papilloma of the bladder,” Journal of Medical Virology, vol. 83, no. 2, pp. 277–285, 2011.
- K. Shigehara, T. Sasagawa, S. Kawaguchi et al., “Prevalence of human papillomavirus infection in the urinary tract of men with urethritis,” International Journal of Urology, vol. 17, no. 6, pp. 563–568, 2010.
- E. M. Ko, R. Tambouret, D. Wilbur, and A. Goodman, “HPV reflex testing in menopausal women,” Pathology Research International, vol. 2011, Article ID 181870, 4 pages, 2011.
- O. Nunobiki, M. Ueda, E. Toji et al., “Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carcinogenesis,” Pathology Research International, vol. 2011, Article ID 364069, 8 pages, 2011.
- H. C. Kitchener, M. Almonte, C. Thomson et al., “HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial,” The Lancet Oncology, vol. 10, no. 7, pp. 672–682, 2009.
- N. Masumoto, T. Fujii, M. Ishikawa et al., “Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients,” Gynecologic Oncology, vol. 94, no. 2, pp. 509–514, 2004.
- G. A. Stanczuk, P. Kay, E. Sibanda et al., “Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix,” Acta Obstetricia et Gynecologica Scandinavica, vol. 82, no. 8, pp. 762–766, 2003.
- M. Q. Zhang, S. K. El-Mofty, and R. M. Dávila, “Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary,” Cancer, vol. 114, no. 2, pp. 118–123, 2008.
- R. M. Triglia, K. Metze, L. C. Zeferino, and L. A. L. Andrade, “HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression,” Gynecologic Oncology, vol. 112, no. 1, pp. 114–118, 2009.
- M. Poljak, I. J. Marin, K. Seme, and A. Vince, “Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail,” Journal of Clinical Virology, vol. 25, Supplement 3, pp. S89–S97, 2002.
- G. M. Clifford, J. S. Smith, M. Plummer, N. Muñoz, and S. Franceschi, “Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis,” British Journal of Cancer, vol. 88, no. 1, pp. 63–69, 2003.
- K. W. K. Lo, Y. F. Wong, M. K. M. Chan et al., “Prevalence of human papillomavirus in cervical cancer: a multicenter study in China,” International Journal of Cancer, vol. 100, no. 3, pp. 327–331, 2002.